Alnylam Pharmaceuticals
ABOUT ALNYLAM
Our Science Is Changing the Way Medicine Treats DiseaseTM
Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life sciences leaders, Alnylam’s vision is to harness the potential of RNAi therapeutics to transform the lives of people living with diseases for which there are limited or inadequate treatment options. Our pioneering work has delivered the world’s first and only approved RNAi therapeutics—ONPATTRO® (patisiran) in 2018, GIVLAARI® (givosiran) in 2019, OXLUMO® (lumasiran) in 2020, and AMVUTTRA® (vutrisiran) in 2022. We are advancing a deep pipeline of innovative RNAi-based medicines in four therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases.
What’s in a Name?
AL-NY-LAM. Our name may not be the easiest to pronounce, but once you learn it, you’ll never forget it. Alnylam is derived from “Alnilam,” the bright center star in the constellation Orion’s belt, which has been used by navigators for thousands of years and symbolizes our passion for discovery.
RNAi Therapeutics—An Innovative New Class of Medicines
Medicines based on RNAi work by “silencing” or disabling the production (“expression”) of the genes that cause specific diseases. In doing so, RNAi therapeutics work “upstream” of most other classes of medicines, such as small molecules and monoclonal antibodies, by targeting the “root” genetic cause of a disease rather than its symptoms. To learn more about our science, click here.
RNAi is the core discovery that forms the therapies Alnylam is developing. It is recognized as a major scientific breakthrough—but how does it work, exactly?
Vision, Mission, and Values
Our Vision - Harnessing a revolution in biology for human health®.
Our Mission - Build a top-tier, global, independent biopharmaceutical company founded on RNAi.
Our Core Values - Commitment to People, Innovation & Discovery, Sense of Urgency, Open Culture, and Passion for Excellence.
CAREERS AT ALNYLAM
Join Our Team and Grow With Us
At Alnylam, we are driven by our mission to translate the Nobel Prize-winning discovery of RNA interference (RNAi) into an innovative, new class of medicines. We’re motivated in this endeavor by the bravery and perseverance of people with unmet medical needs who live with rare and genetic diseases. They are the focus of our efforts, and we exist as a company because of them. That knowledge and commitment to patients is present in everything we do, every day.
At The Forefront of What’s Next
For Patients
Our goal, which is well underway, is to become a world-class biopharmaceutical company that can independently develop and deliver innovative medicines based on RNAi to patients worldwide. We have a deep pipeline of early to late stage investigational therapies, and 2018 marked the approval of our first medicine—the world’s first RNAi therapeutic. Even though we’ve been around since 2002, we’re just getting started!
For Employees
We are growing quickly and hiring across North America, Europe, Asia, and Latin America for a wide variety of roles. We’re seeking smart, passionate, “change the world” kind of people who are ready to say, “challenge accepted.” Our 1,500 (and counting!) employees are building a diverse, equitable, inclusive, and high-performing global organization that celebrates team achievement and recognizes individual contributions.
We’re at the forefront of what’s next for patients, and perhaps your career also.
Search among Alnylam Pharmaceuticals jobs
| Jobs: 1 - 10 of 97 |
VP, Global Scientific Communications
Cambridge, Massachusetts
Position Summary Alnylam Pharmaceuticals is seeking an accomplished and visionary Vice President, Global Scientific Communications to lead the strategic development and execution of global scientific communication activities across our port...
3h
| Job Type | Full Time |
Cambridge, Massachusetts
Director, Epidemiology Overview The Director, Epidemiology is responsible for representing the Epidemiology function at Alnylam providing expertise, strategic vision, and oversight of epidemiology and real-world evidence (RWE) activities in...
3h
| Job Type | Full Time |
Cambridge, Massachusetts
Director, Clinical Science Overview: The Director, Clinical Science will be a member of the global clinical development team, working closely with other members of the clinical research group within clinical development (medical lead, medic...
3h
| Job Type | Full Time |
Director, Head of Incentive Compensation & Execution Excellence
Cambridge, Massachusetts
Overview: The Director of Sales Execution & Enablement is responsible for designing, operationalizing, and driving adoption of incentive compensation programs and field enablement initiatives that improve execution, behavior change, and mea...
1d
| Job Type | Full Time |
Associate Director, Field Reimbursement - Great Lakes North
Minneapolis, Minnesota
Overview: Reporting to the Field Reimbursement Director, Lead, the Associate Director, Field Reimbursement will optimize access to Alnylam products in his/her region by understanding and addressing reimbursement and patient access challenge...
1d
| Job Type | Full Time |
Director, Global Market Access
Cambridge, Massachusetts
Overview: Reporting to the VP, Global Market Access, the candidate will act as the overall lead for global pricing & market access strategy for Alnylam's Rare Disease portfolio, as well as for selected pipeline assets, bringing key learning...
3d
| Job Type | Full Time |
Associate Director, Commercial Consent, Identity & Preference Management
Cambridge, Massachusetts
Overview: Alnylam is seeking an experienced and highly collaborative Associate Director, Commercial Consent, Identity & Preference Management to lead the Commercial business capability needed to capture, manage and honor consent, identity a...
3d
| Job Type | Full Time |
Cambridge, Massachusetts
Overview: The Translational Research Team at Alnylam is seeking a highly motivated Proteomics Scientist to join our LC/MS-based 'omics group dedicated to advancing RNAi therapeutics through preclinical target validation, biomarker discovery...
4d
| Job Type | Full Time |
Director, Clinical Research- Benign Hematology
Cambridge, Massachusetts
Overview Alnylam Pharmaceuticals is seeking an imaginative physician drug developer, with the flexibility and confidence to work across diseases within the neurology and hematology therapeutic area. This role includes the opportunity to pro...
4d
| Job Type | Full Time |
Cambridge, Massachusetts
Overview: The Vice President, Strategic Planning is a senior enterprise leader and key member of the Financial & Strategic Planning leadership team, serving as a strategic partner and trusted advisor to the SVP, Financial & Strategic Planni...
4d
| Job Type | Full Time |